For examples, VPA in combination with low-dosed interferon α, or AEE788 (a receptor tyrosine kinase inhibitor), or RAD001 (an inhibitor of mTOR), is much more effective in inhibiting HDAC activity and cell proliferation in RCC cell [63]. Here, HDAC9 is linked to renal cell carcinoma.